BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1680875)

  • 21. Treatment of gastroesophageal (acid) reflux with lansoprazole: an overview.
    Dobrilla G; Di Fede F
    Clin Ther; 1993; 15 Suppl B():2-13. PubMed ID: 7911400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of gastroesophageal reflux disease].
    Essilfie I; Hoff DA; Hatlebakk JG
    Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3082-4. PubMed ID: 18049500
    [No Abstract]   [Full Text] [Related]  

  • 23. Gastroesophageal reflux disease: current treatment approaches.
    Biddle W
    Director; 2003; 11(4):155-9. PubMed ID: 14608699
    [No Abstract]   [Full Text] [Related]  

  • 24. Gastroesophageal reflux disease: an update on management.
    Hogan WJ
    J Clin Gastroenterol; 1990; 12 Suppl 2():S21-8. PubMed ID: 1978843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incompetent lower esophageal sphincter.
    Belafsky PC
    Ear Nose Throat J; 2004 May; 83(5):318. PubMed ID: 15195875
    [No Abstract]   [Full Text] [Related]  

  • 26. Respiratory complications of gastroesophageal reflux.
    Gonzalez ER; Castell DO
    Am Fam Physician; 1988 Feb; 37(2):169-72. PubMed ID: 2894146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
    Vasil'ev IuV; Li IA
    Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical treatment of gastroesophageal reflux disease: options and priorities.
    Thomson AB
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():14-23. PubMed ID: 1349550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of pre-endoscopy proton pump inhibitor use on the classification of non-erosive reflux disease and erosive oesophagitis.
    Gaddam S; Wani S; Ahmed H; Maddur P; Hall SB; Gupta N; Puli SR; Higbee A; Rastogi A; Bansal A; Sharma P
    Aliment Pharmacol Ther; 2010 Nov; 32(10):1266-74. PubMed ID: 20955446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopy-negative reflux disease.
    Carlsson R; Holloway RH
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Oct; 14(5):827-37. PubMed ID: 11003812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of gastroesophageal reflux: analysis of randomized double-blind trials].
    Pignon JP; Poynard T; Naveau S; Sebag G; Chaput JC
    Gastroenterol Clin Biol; 1987 Oct; 11(10):668-80. PubMed ID: 2891580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy for gastroesophageal reflux disease: more is not necessarily better.
    Metz DC
    Am J Gastroenterol; 2003 Sep; 98(9):1913-5. PubMed ID: 14499765
    [No Abstract]   [Full Text] [Related]  

  • 34. Dexlansoprazole: A proton pump inhibitor with a dual delayed-release system.
    Emerson CR; Marzella N
    Clin Ther; 2010 Aug; 32(9):1578-96. PubMed ID: 20974316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical therapy of extraesophageal gastroesophageal reflux disease.
    Katz PO
    J Clin Gastroenterol; 2000 Apr; 30(3 Suppl):S42-4. PubMed ID: 10777172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The proton pump inhibitor test for gastroesophageal reflux disease: optimal cut-off value and duration.
    de Leone A; Tonini M; Dominici P; Grossi E; Pace F;
    Dig Liver Dis; 2010 Nov; 42(11):785-90. PubMed ID: 20452300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on gastroesophageal reflux disease.
    Ledger S
    CANNT J; 2005; 15(4):44-7; quiz 48-9. PubMed ID: 16491998
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapeutic procedures in gastroesophageal reflux disease].
    Tytgat GN
    Z Gastroenterol; 1986 Sep; 24 Suppl 2():40-4. PubMed ID: 2877526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
    Leite LP; Just RJ; Castell DO; Lagerström PO
    Am J Gastroenterol; 1995 Oct; 90(10):1874-7. PubMed ID: 7572913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gastroesophageal reflux and esophagitis (II). Treatment guidelines].
    Velasco A; Alvarez FJ
    Rev Esp Enferm Dig; 1991 Jun; 79(6):416-23. PubMed ID: 1910920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.